Eltrombopag (EPAG) for the treatment of patients aged ≥65 years with chronic immune thrombocytopenia (CITP): Safety and efficacy results from the extend study

Authors
Category Primary study
JournalHaematologica
Year 2017
This article has no abstract
Epistemonikos ID: 45b7e22bdf4bb66678806ad48e326bd9c9625dd1
First added on: Feb 08, 2025